(IN BRIEF) Brenntag has signed an exclusive European distribution agreement with ArcticZymes AS for its line of salt-active nucleases—SAN HQ, SAN-HQ GMP, M-SAN HQ, and M-SAN HQ GMP—used in gene therapy, vaccine manufacturing, and bioprocessing. Signed during the CPHI fair … Read the full press release
Posted in Business, Chemicals, Financial, Germany, Industrial, Management, Pharma & Biotech
Tagged ArcticZymes, biopharma, biopharmaceutical innovation, bioprocessing, biotechnology, Brenntag, Brenntag and ArcticZymes Join Forces to Support Growth in Biopharmaceutical and Gene Therapy Markets, CPHI Frankfurt, downstream processing, enzyme distribution, enzymes, European partnership, gene therapy, GMP, Joakim Rehné, life sciences, M-SAN HQ, nucleases, Paul Blackburn, SAN HQ, vaccine manufacturing
(IN BRIEF) The European Investment Bank and European Commission are jointly supporting BioNTech’s mRNA manufacturing facility in Kigali, Rwanda, with up to €95 million in blended financing. The project aims to strengthen Africa’s capacity to produce vaccines locally for diseases … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Investment, Luxembourg, News, Pharma & Biotech, Technology
Tagged Africa CDC, African Union, and CEPI Join Forces to Strengthen Africa’s Vaccine Independence Through BioNTech’s Kigali mRNA Facility, BioNTech, BioNTech Secures up to €95 Million in EU and EIB Financing to Boost Vaccine Manufacturing Capacity in Kigali, biotechnology, CEPI, Dr Amadou Sall, EIB, EU, European Commission, European Investment Bank, Global Gateway, HIV, Jozef Sikela, Karl Nehammer, Kigali, local production, malaria, mpox, mRNA Vaccines, public health, Rwanda, Sierk Poetting, Sustainable Healthcare, Team Europe, tuberculosis, Vaccine Innovation, vaccine manufacturing
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?